Mesothelioma and Thymic Tumors

Chapter

Abstract

This chapter will discuss the workup and management of mesothelioma and thymic tumors, with an emphasis on external beam radiotherapy technique and published evidence.

Keywords

Mesothelioma Thymoma Thymic carcinoma Radiation therapy 

Notes

Acknowledgment

We thank Fred Y. Wu MD, PhD, Brian Lee MD, PhD, and Joycelyn L. Speight MD, PhD for their work on the prior edition of this chapter.

References

  1. Allen AM, Czerminska M, Janne PA, et al. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma. Int J Radiat Oncol Biol Phys. 2006;65(3):640–5.CrossRefGoogle Scholar
  2. Allen AM, Schoenfield MS, Hacker F, et al. Restricted field IMRT dramatically enhances IMRT planning for mesothelioma. Int J Radiat Oncol Biol Phys. 2007a;69(5):1587–92.CrossRefGoogle Scholar
  3. Allen AM, Den R, Wong JS, et al. Influence of radiotherapy technique and dose on patterns of failure for mesothelioma patients after extrapleural pneumonectomy. Int J Radiat Oncol Biol Phys. 2007b;68(5):1366–74.CrossRefGoogle Scholar
  4. Boutin C, Rey F, Viallat R, et al. Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy. Chest. 1995;108(3):754–8.CrossRefGoogle Scholar
  5. Cao C, Tian D, Park J, et al. A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma. Lung Cancer. 2014;83(2):240–5.CrossRefGoogle Scholar
  6. Clive A, Taylor H, Dobson L, et al. Prophylactic radiotherapy for the prevention of procedure-tract metastases after surgical and large-bore pleural procedures in malignant pleural mesothelioma (SMART): a multicenter, open-label, phase 3, randomized controlled trial. Lancet Oncol. 2016;17(8):1094–104.CrossRefGoogle Scholar
  7. Curran WJ Jr, Kornstein MJ, Brooks JJ, et al. Invasive thymoma: the role of mediastinal irradiation following complete or incomplete surgical resection. J Clin Oncol. 1988;6:1722–7.CrossRefGoogle Scholar
  8. Flores R, Krug L, Rosenzweig K, et al. Induction chemotherapy, extrapleural pneumonectomy, and postoperative high-dose radiotherapy for locally advanced malignant pleural mesothelioma: a phase II trial. J Thorac Oncol. 2006;1:289–95.CrossRefGoogle Scholar
  9. Flores R, Pass H, Seshan V, et al. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. J Thorac Cardiovasc Surg. 2008;135(3):620–6.CrossRefGoogle Scholar
  10. Forquer JA, Rong N, Fakiris AJ, et al. Postoperative radiotherapy after surgical resection of thymoma: differing roles in localized and regional disease. Int J Radiat Oncol Biol Phys. 2010;76(2):440–5.CrossRefGoogle Scholar
  11. Gupta V, Mychalczak B, Krug L, et al. Hemithoracic radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys. 2005;63(4):1045–52.CrossRefGoogle Scholar
  12. Kim E, Putnam J, Komaki R, et al. Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report. Lung Cancer. 2004;44:369–79.CrossRefGoogle Scholar
  13. Komaki R, Travis EL, Cox JD. The lung and thymus. In: Cox JD, Ang KK, editors. Radiation oncology: rationale, technique, results. 8th ed. St. Louis: Mosby; 2003. p. 399–427.Google Scholar
  14. Kondo K, Monden Y. Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan. Ann Thorac Surg. 2003;76(3):878–84.CrossRefGoogle Scholar
  15. Korst R, Kansler A, Christos P, et al. Adjuvant radiotherapy for thymic epithelial tumors: a systematic review and meta-analysis. Ann Thorac Surg. 2009;87(5):1641–7.CrossRefGoogle Scholar
  16. Krayenbuhl J, OErtel S, Davis JB, et al. Combined photon and electron three-dimensional conformal versus intensity-modulated radiotherapy with integrated boost for adjuvant treatment of malignant pleural mesothelioma after pleuropneumectomy. Int J Radiat Oncol Biol Phys. 2007;69(5):1593–9.CrossRefGoogle Scholar
  17. Lim Y, Kim H, Wu HG. Role of postoperative radiotherapy in nonlocalized thymoma: propensity-matched analysis of surveillance, epidemiology and end results database. J Thorac Oncol. 2015;10(9):1357–63.CrossRefGoogle Scholar
  18. Loehrer PJ, Chen M, Kim K, et al. Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial. J ClinOncol. 1997;15(9):3093–9.CrossRefGoogle Scholar
  19. Masaoka A, Monden Y, Nakahara K, et al. Follow-up study of thymomas with special reference to their clinical stages. Cancer. 1981;48:2485.CrossRefGoogle Scholar
  20. Miles EF, Larrier NA, Kelsey CR, et al. Intensity modulated radiotherapy for restricted mesothelioma: the Duke experience. Int J Radiat Oncol Biol Phys. 2008;71(4):1143–50.CrossRefGoogle Scholar
  21. Mornex F. Radiotherapy and chemotherapy for invasive thymomas: a multicentric retrospective review of 90 cases. Int J Radiat Oncol Biol Phys. 1995;2:651–9.CrossRefGoogle Scholar
  22. O’Rourke N, Garcia JC, Paul J, et al. A randomized controlled trial of intervention site radiotherapy in malignant pleural mesothelioma. Radiother Oncol. 2007;84(1):18–22.CrossRefGoogle Scholar
  23. Omasa M, Date H, Sozu T, et al. Postoperative radiotherapy is effective for thymic carcinoma but not for thymoma in stage II and III thymic epithelial tumors: the Japanese Association for Research on the Thymus Database Study. Cancer. 2015;121(7):1008–16.CrossRefGoogle Scholar
  24. Rice DC, Stevens CW, Correa AM, et al. Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma. Ann Thorac Surg. 2007;84(5):1685–92.CrossRefGoogle Scholar
  25. Rimmer A, Zauderer M, Gomez D, et al. Phase II study of hemithoracic intensity-modulated pleural radiation (IMPRINT) as part of lung-sparing multimodality therapy in patients with malignant pleural mesothelioma. J Clin Oncol. 2016;34(23):2761–8.CrossRefGoogle Scholar
  26. Rusch VW, Rosenzweig K, Venkatraman E, et al. A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 2001;122:788–95.CrossRefGoogle Scholar
  27. Sterzing F, Sroka-Perez G, Schubert K, et al. Evaluating target coverage and normal tissue sparing in the adjuvant radiotherapy of malignant pleural mesothelioma: helical tomotherapy compared with step and shoot IMRT. Radiother Oncol. 2008;86(2):251–7.CrossRefGoogle Scholar
  28. Treasure T, Lang-Lazdunski L, Waller D, et al. Extra-pleural pneumonectomy vs no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the mesothelioma and radical surgery (MARS) randomized feasibility study. Lancet Oncol. 2011;12(8):763–72.CrossRefGoogle Scholar
  29. Utsumi T, Shiono H, Kadota Y, et al. Postoperative radiation therapy after complete resection of thymoma has little impact on survival. Cancer. 2009;115(23):5413–20.CrossRefGoogle Scholar
  30. Van Schil P, Baas P, Gaafar R, et al. Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicenter trial. Eur Respir J. 2010;36(6):1362–9.CrossRefGoogle Scholar
  31. Vogelzang NJ, Rusthoven JJ, Symanowski J, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol. 2003;21:2636–44.CrossRefGoogle Scholar
  32. Wright CD, Choi NC. Wain JC, et al induction chemoradiotherapy followed by resection for locally advanced Masaoka stage III and IVA thymic tumors. Ann Thorac Surg. 2008;85(2):385–9.CrossRefGoogle Scholar
  33. Zalcman G, Mazieres J, Margery J, et al. Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomized, controlled, open-label, phase 3 trial. Lancet. 2016;387(10026):1405–14.CrossRefGoogle Scholar
  34. Zhu G, He S, Fu X, Jiang G, Liu T. Radiotherapy and prognostic factors for thymoma: a retrospective study of 175 patients. Int J Radiat Oncol Biol Phys. 2004;60(4):1113–9. doi: 10.1016/j.ijrobp.2004.05.013.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Radiation Oncology, University of California San FranciscoSan FranciscoUSA
  2. 2.Radiation OncologyUniversity of Southern CaliforniaLos AngelesUSA

Personalised recommendations